LETTERS TO THE EDITOR

LETTERS/COLUMNS: SEND LETTERS TO THE EDITOR FOR PUBLISHING TO FRONTPAGENEWS1@YAHOO.COM. PLEASE INCLUDE DAY/EVENING/ CELL NUMBER, HOME NUMBER, AND EMAIL. CONTACT VAN STONE: FRONTPAGENEWS1@YAHOO.COM OR (215) 821-9147 TO SUBMIT A REQUEST FOR ANY WRITER. PLEASE DO NOT CONTACT THE WRITER DIRECTLY! ALL APPEARANCE REQUEST WILL GO THROUGH THE MANAGING EDITOR'S OFFICE. COPYRIGHT: THE USE OF ANY SUBMISSIONS APPEARING ON THIS SITE FOR MONETARY GAINS IS STRICTLY PROHIBITED. TO LEARN MORE: PHILADELPHIA FRONT PAGE NEWS WWW.FPNNEWS.ORG. YOUR TOP STORIES OF THE DAY (215) 821-9147.

Wednesday, July 16, 2014

Studies see new risks for cholesterol drug niacin

Studies see new risks for cholesterol drug niacin 

AP Photo
FILE - In this Wednesday, May 15, 2013, file photo, a pharmacist works at his desk located next to the prescription pick up counter in New York. New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health.


New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.

Niacin is a type of B vitamin long sold over the counter and in higher prescription doses. Some people take it alone or with statin medicines such as Lipitor for cholesterol problems.

Niacin users' main complaint has been flushing, so drug companies have been testing extended-release and combining other medicines with it to minimize that problem. Introduced in the 1950s, the drug hadn't been rigorously tested until recent years when makers of prescription versions were seeking market approval.

The two studies were testing prescription versions of niacin, and the bottom line - that it didn't help prevent heart problems any more than statins alone do - has already been announced. Some of the side effect information, including a troubling rise in deaths among niacin users in one study, also was known but many doctors have been waiting for full details and verification of the results before drawing firm conclusions about the drug's safety and effectiveness.

Those details are in this week's New England Journal of Medicine.

The larger study suggests that "for every 200 people that we treat with niacin, there is one excess death," plus higher rates of bleeding, infections and other problems - "a completely unacceptable level" of harm, said Dr. Donald Lloyd-Jones of Northwestern University in Chicago. "Niacin should not be used routinely in clinical practice at all."

He co-led a panel for the American Heart Association and American College of Cardiology that recently issued new cholesterol treatment guidelines. The group did not recommend niacin but said it could be considered for certain patients. If the panel had seen the new results, it "almost certainly" would have recommended against niacin's routine use, Lloyd-Jones said.

Heart specialists stress that patients never should stop taking any medicine without first talking with their doctors. Many have shied away from niacin since the initial results came out, but more than 700,000 prescriptions for various niacin drugs are written each month in the U.S. The top brand is Niaspan, long sold by Abbott Laboratories and now by AbbVie, which had nearly $900 million in sales in the U.S. alone last year, according to IMS Health, a health data firm.

The larger of the two studies tested Tredaptive - a Merck & Co. combo of niacin and an anti-flushing medicine - in nearly 26,000 people already taking a statin. Full results confirm there was a 9 percent increase in the risk of death for those taking the drug - a result of borderline statistical significance, meaning the difference could have occurred by chance alone, but still "of great concern," Lloyd-Jones wrote in a commentary in the medical journal.

The drug also brought higher rates of gastrointestinal and muscle problems, infections and bleeding. More diabetics on the drug lost control of their blood sugar, and there were more new cases of diabetes among niacin users.

The initial results in December 2012 led Merck to stop pursuing approval of Tredaptive in the U.S. and to tell doctors in dozens of countries where it was sold to stop prescribing it to new patients.

Prompted by that study, leaders of an earlier one that tested a different niacin drug, Niaspan, re-examined side effects among their 3,414 participants and detailed them in a letter in the medical journal.

Besides more gastrointestinal, blood-sugar and other complications, the new report details a higher rate of infections and a trend toward higher rates of serious bleeding.

The consistency of the results on studies testing multiple types of niacin "leaves little doubt that this drug provides little if any benefits and imposes serious side effects," said Yale University cardiologist Dr. Harlan Krumholz.

"It's an astonishing reversal of fortune" for niacin, one of the very earliest cholesterol treatments, he said. 

"This is a billion-dollar drug and it never really had the evidence to warrant that sort of blockbuster status."

The studies were on prescription niacin; risks and benefits of over-the-counter forms are unclear.

Lloyd-Jones said niacin still may be appropriate for some people with very high heart risks who cannot take statins, and for people with very high triglycerides that can't be controlled through other means.

Krumholz said patients should talk with doctors about other treatment options besides niacin.

"This drug can hurt you," he said.

Van Stone Productions Inc. 501C3 Nonprofit Organization Informatioin (EIN) / Tax ID

Van Stone Productions Inc. 501C3 Nonprofit Organization Informatioin (EIN) / Tax ID
Click on the logo to learn about the non-profit status

BECOME OUR VLOGGER OF THE MONTH: VIDEO NEWS CONTENT PUBLISHED ON ANY TOPIC BELOW

Latest edition of Talk Live Philly With Van Stone

VAN STONE PERFORMANCE PROMOTION VIDEO AT WEST PHILADELPHIA HS 1999 - BELOW

FPN NEWS “TAKE TIME FOR WINNERS IN ANY COMMUNITY!”

Van Stones' Beautiful World Images -Latinamerica, South Asia, and USA Fashion and Beauty Collection

Van Stones' Beautiful World Images -Latinamerica, South Asia, and USA Fashion and Beauty Collection
Family Modeling -modelado de la familia

Van Stones' Beautiful World Images -Hermosas World Images Van Stones

Van Stones' Beautiful World Images -Hermosas World Images Van Stones
Family Modeling -modelado de la familia

WE'RE #1

WE'RE #1

Van Stones' Beautiful World Images -Hermosas World Images Van Stones

Van Stones' Beautiful World Images -Hermosas World Images Van Stones
Family Modeling -modelado de la familia

Van Stones' Beautiful Tween Images-Hermosas Imágenes Tween Van Stones

Van Stones' Beautiful Tween Images-Hermosas Imágenes Tween Van Stones
Family Modeling -modelado de la familia

WE'RE NO 1

WE'RE NO 1

Van Stones' Beautiful Youth Images -Van Stones imágenes hermosas de la Juventud

Van Stones' Beautiful Youth Images -Van Stones imágenes hermosas de la Juventud
Family Modeling -Modelado de la familia

WE'RE NO 1

WE'RE NO 1

Van Stones' Beautiful Child Images -Van Stones Niño hermoso Imágenes

WE'RE #1

Van Stones’ Beautiful Children Images - Van Stones imágenes hermosas Madre

Van Stones’ Beautiful Children Images - Van Stones imágenes hermosas Madre
Family Modeling -modelado de la familia

Like Us On Facebook

We"re Looking For Volunteers

News, and more about youth, education, political analyst, schools, anti-violence, social justice, grass roots democracy, ecological protection, seniors, Historic Preservation & Restoration, (Black, Latinos, Asian, Pakistani, Italian, and other)Arts, Books, Super Heroes, Trading Cards, Youth, College, and Pro Sports, Nonprofits and Real-estate.

Blog Archive

About Us

  • FPN can reach out to Representatives from your side of: The Village, The Township, or The City
  • FPN features
    Sports
    Cars
    Family Entertainment
    Neighborhood News
    Scholastic News
    Regional News
    National News
    Citywide News
    Legal News
    Alternative Green Energy Education News
    Superhero & Comic Strip News
  • Teen Stars
  • Humanitarian/Ministers/Political
  • Community Services
  • Women & Men & Kids

  • You acknowledge and agree that you may not copy, distribute, sell, resell or exploit for any commercial purposes, any portion of the Newspaper or Services. Unless otherwise expressly provided in our Newspaper, you may not copy, display or use any trademark without prior written permission of the trademark owner.

    FPN/VSP® is in no way responsible for the content of any site owned by a third party that may be listed on our Website and/or linked to our Website via hyperlink. VSP/FPN® makes no judgment or warranty with respect to the accuracy, timeliness or suitability of the content of any site to which the Website may refer and/or link, and FPN/VSP® takes no responsibility therefor. By providing access to other websites, FPN/VSP® is not endorsing the goods or services provided by any such websites or their sponsoring organizations, nor does such reference or link mean that any third party websites or their owners are endorsing FPN/VSP® or any of the Services. Such references and links are for informational purposes only and as a convenience to you.

    FPN/VSP® reserves the right at any time to modify or discontinue, temporarily or permanently, the Website and/or Services (or any part thereof) with or without notice to you. You agree that neither FPN/VSP® nor its affiliates shall be liable to you or to any third party for any modification, suspension or discontinuance of the Website and/or Services.

    You agree to indemnify and hold harmless FPN/VSP®, its subsidiaries, and affiliates, and their respective officers, directors, employees, shareholders, legal representatives, agents, successors and assigns, from and against any and all claims, actions, demands, causes of action and other proceedings arising from or concerning your use of the Services (collectively, "Claims") and to reimburse them on demand for any losses, costs, judgments, fees, fines and other expenses they incur (including attorneys' fees and litigation costs) as a result of any Claims.

    The Website is © 2009 by VSP®, or its designers. All rights reserved. Your rights with respect to use of the Website and Services are governed by the Terms and all applicable laws, including but not limited to intellectual property laws.

    Any contact information for troops overseas and/or soldiers at home provided to you by FPN/VSP® is specifically and solely for your individual use in connection with the services provide by Van Stone Productions Foundation VSP.

    FPN/VSP® soldiers contact information for any other purpose whatsoever, including, but not limited to, copying and/or storing by any means (manually, electronically, mechanically, or otherwise) not expressly authorized by FPN/VSP is strictly prohibited. Additionally, use of FPN/VSP® contact information for any solicitation or recruiting purpose, or any other private, commercial, political, or religious mailing, or any other form of communication not expressly authorized by FPN/VSP® is strictly prohibited.